Search

everythinglearnresearchcommunity

for

Search:↓

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Pimozide treatment resolved cysts and partially restored cheek fat in a man with Barraquer–Simons syndrome.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Both steroid treatments effectively regrow hair in severe alopecia areata.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Minoxidil in distearyldimethylammonium chloride vesicles significantly promotes hair growth, while minoxidil in microparticles or poloxamer solutions doesn't.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Targeted immune modulation can help achieve stable remission in alopecia areata.

FK506 may stimulate hair growth when applied to the skin.

Fluphenazine and iloprost can induce hair growth.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Combining oral prednisolone and topical minoxidil effectively reduces hair loss and promotes regrowth in alopecia areata.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Cyclosporin A helps damaged hair follicles regrow hair quickly.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.